Corebridge Files Equitable Financials and Pro Forma Combined Statements for Pending Merger
CRBG sits 55% above its 52-week low of $22.19.
Summary
Corebridge filed Equitable's audited and unaudited financial statements and pro forma combined financial information for the pending all-stock merger, providing the first detailed view of the combined entity's financials.
Key Events · M&A and Partnerships · CRBG
-
Equitable Financial Statements Filed
Corebridge filed Equitable's audited consolidated financial statements as of December 31, 2025 and 2024 and for the years ended December 31, 2025, 2024 and 2023, along with unaudited statements as of June 30, 2026 and for the three and six months ended June 30, 2026 and 2025.
-
Pro Forma Combined Financials Disclosed
The filing includes unaudited pro forma condensed combined balance sheet of New Equitable as of June 30, 2026 showing total assets of $762.9 billion and total liabilities of $734.0 billion, and pro forma income statements for the six months ended June 30, 2026 and year ended December 31, 2025.
-
Pro Forma Net Income
Pro forma net income available to common stockholders was $124 million for the six months ended June 30, 2026, compared to a pro forma loss of $1.77 billion for the year ended December 31, 2025.
-
Merger Timeline
The merger agreement was announced on March 26, 2026, and shareholders of both companies approved the transaction on July 30, 2026. The transaction is expected to close by the end of 2026, subject to regulatory approvals.
Analysis · CRBG · Finance
This 8-K provides the audited and unaudited financial statements of Equitable Holdings and the pro forma combined financial information for the all-stock merger with Corebridge. The pro forma data shows the combined entity would have total assets of $762.9 billion and total liabilities of $734.0 billion, with pro forma net income available to common stockholders of $124 million for the first half of 2026. These disclosures are required for the registration statement and give investors the first detailed look at the combined company's financial position and results.
At the time of this filing, CRBG was trading at $34.30 on NYSE in the Finance sector, with a market capitalization of approximately $15.4B. The 52-week trading range was $22.19 to $35.22. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.